FTC Probes King Pharmaceuticals In Antitrust Inquiry
As part of its investigation into the potential anti-competitive effects of authorized generics of brand-name drugs, the Federal Trade Commission has requested information from King Pharmaceuticals Inc. related to a patent...To view the full article, register now.
Already a subscriber? Click here to view full article